Concerta is a prescription medication (extended-release methylphenidate) indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults.
Concerta is a brand of extended-release methylphenidate hydrochloride, a central nervous system stimulant primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 and older, adolescents, and adults. Manufactured by Janssen Pharmaceuticals, Concerta utilizes a unique osmotic delivery system (OROS) to release medication gradually throughout the day, allowing for once-daily dosing.
This category provides access to patient information leaflets, prescribing information, medication guides, and dosing instructions associated with Concerta products. Users can find details regarding dosage strengths, contraindications, warnings, and proper handling of the medication.
Llawlyfrau diweddaraf gan manuals+ wedi'i guradu ar gyfer y brand hwn.
Cwestiynau cyffredin am lawlyfrau, cofrestru, a chymorth ar gyfer y brand hwn.
Concerta is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65.
Concerta should be taken once daily in the morning with or without food. The tablet must be swallowed whole with liquids and should not be chewed, crushed, or divided.
The FDA-approved Medication Guide is typically provided with the prescription and can also be found on the official Concerta website or within the documents provided on this page.